Inpharma Weekly

, Volume 1572, Issue 1, pp 6–6 | Cite as

Epratuzumab plus rituximab make the cut with CHOP therapy for DLBCL

Clinical study
  • 4 Downloads

Keywords

Survival Rate Lymphoma Systemic Lupus Erythematosus Pilot Study Doxorubicin 

Copyright information

© Adis International Ltd 2007

Personalised recommendations